Literature DB >> 19731255

Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma.

Gursah Kats-Ugurlu1, Ilse Roodink, Mirjam de Weijert, Dorien Tiemessen, Cathy Maass, Kiek Verrijp, Jeroen van der Laak, Rob de Waal, Peter Mulders, Egbert Oosterwijk, William Leenders.   

Abstract

Tumour metastasis is the result of a complex sequence of events, including migration of tumour cells through stroma, proteolytic degradation of stromal and vessel wall elements, intravasation, transport through the circulation, extravasation and outgrowth at compatible sites in the body (the 'seed and soil' hypothesis). However, the high incidence of metastasis from various tumour types in liver and lung may be explained by a stochastic process as well, based on the anatomical relationship of the primary tumour with the circulation and mechanical entrapment of metastatic tumour cells in capillary beds. We previously reported that constitutive VEGF-A expression in tumour xenografts facilitates this type of metastatic seeding by promoting shedding of multicellular tumour tissue fragments, surrounded by vessel wall elements, into the circulation. After transport through the vena cava, such fragments may be trapped in pulmonary arteries, allowing them to expand to symptomatic lesions. Here we tested whether this process has clinical relevance for clear cell renal cell carcinoma (ccRCC), a prototype tumour in the sense of high constitutive VEGF-A expression. To this end we collected and analysed outflow samples from the renal vein, directly after tumour nephrectomy, in 42 patients diagnosed with ccRCC. Tumour fragments in venous outflow were observed in 33% of ccRCC patients and correlated with the synchronous presence or metachronous development of pulmonary metastases (p < 0.001, Fisher's exact test). In patients with tumours that, in retrospect, were not of the VEGF-A-expressing clear cell type, tumour fragments were never observed in the renal outflow. These data suggest that, in ccRCC, a VEGF-A-induced phenotype promotes a release of tumour cell clusters into the circulation that may contribute to pulmonary metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731255     DOI: 10.1002/path.2613

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  33 in total

1.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

Authors:  Edward H Cho; Marco Wendel; Madelyn Luttgen; Craig Yoshioka; Dena Marrinucci; Daniel Lazar; Ethan Schram; Jorge Nieva; Lyudmila Bazhenova; Alison Morgan; Andrew H Ko; W Michael Korn; Anand Kolatkar; Kelly Bethel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

2.  Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Authors:  Marco Wendel; Lyudmila Bazhenova; Rogier Boshuizen; Anand Kolatkar; Meghana Honnatti; Edward H Cho; Dena Marrinucci; Ajay Sandhu; Anthony Perricone; Patricia Thistlethwaite; Kelly Bethel; Jorge Nieva; Michel van den Heuvel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

3.  Circulating tumor cell detection in high-risk non-metastatic prostate cancer.

Authors:  Jasmin Loh; Lidija Jovanovic; Margot Lehman; Anne Capp; David Pryor; Monica Harris; Colleen Nelson; Jarad Martin
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-16       Impact factor: 4.553

Review 4.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

5.  Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study.

Authors:  Costanza Paoletti; Jieling Miao; Emily M Dolce; Elizabeth P Darga; Madeline I Repollet; Gerald V Doyle; Julie R Gralow; Gabriel N Hortobagyi; Jeffrey B Smerage; William E Barlow; Daniel F Hayes
Journal:  Clin Cancer Res       Date:  2019-07-29       Impact factor: 12.531

6.  Circulating tumor cells as a window on metastasis biology in lung cancer.

Authors:  Jian-Mei Hou; Matthew Krebs; Tim Ward; Robert Sloane; Lynsey Priest; Andrew Hughes; Glen Clack; Malcolm Ranson; Fiona Blackhall; Caroline Dive
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 7.  CTC clusters in cancer progression and metastasis.

Authors:  Anna Fabisiewicz; Ewa Grzybowska
Journal:  Med Oncol       Date:  2016-12-23       Impact factor: 3.064

8.  EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas.

Authors:  Alexcia Camila Braun; Celso Abdon Lopes de Mello; Marcelo Corassa; Emne Ali Abdallah; Ana Cláudia Urvanegia; Vanessa Silva Alves; Bianca C T C P Flores; Mônica Díaz; Ulisses Ribaldo Nicolau; Virgilio Souza E Silva; Vinicius Calsavara; Patrizia Paterlini-Brechót; Ludmilla Thomé Domingos Chinen
Journal:  Cancer Biol Ther       Date:  2018-03-21       Impact factor: 4.742

9.  Probing 3D Collective Cancer Invasion Using Double-Stranded Locked Nucleic Acid Biosensors.

Authors:  Zachary S Dean; Paul Elias; Nima Jamilpour; Urs Utzinger; Pak Kin Wong
Journal:  Anal Chem       Date:  2016-08-16       Impact factor: 6.986

Review 10.  Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.

Authors:  Sumitra Mohan; Francesca Chemi; Ged Brady
Journal:  Transl Lung Cancer Res       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.